Literature DB >> 18281206

Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.

Faran Emmanuel1, Mehreen Fatima.   

Abstract

BACKGROUND: HIV Surveillance data from IDUs is suggestive of an escalating epidemic in major cities of Pakistan. The relatively widespread presence and interlinking of IDU and high-risk sexual networks, combined with low levels of HIV knowledge and prevention methods, indicate that there is potential for a rapid spread of HIV to other high-risk groups and its further expansion to general population through bridging groups.
METHODS: We reviewed Second Generation Surveillance data which provides mapping, biological and behavioural information from IDUs in eight major cities across Pakistan. Geographic mapping provided information about the location and size of the population, which was followed by a behavioural survey, conducted with a representative sample of 2432 IDUs. In addition, blood samples were also obtained which were tested for HIV.
RESULTS: Despite availability of syringe and needle exchange programmes in larger cities, drug users continued to reuse syringes (78.1%), injected in groups (73.3%) where extensive sharing of needle and injecting paraphernalia took place (50%). 12.6% of the respondents reported to having sexual relationships with female sex workers and 14.7% had sex with males in the past 6 months. 65% never used condoms. In addition 5.3% reported exchange of sex for money and drugs. Fairly low levels of coverage were reported from most of the cities.
CONCLUSION: Despite an existing nationwide harm reduction programme, increasing rates of HIV infection among IDUs underscore the need to identify gaps in the existing prevention strategy. Data available on coverage shows that effective harm reduction activities are unable to reach a substantial number of IDUs to actually avert or delay the emerging IDUs epidemic. There is an urgent need to expand coverage, and to integrate harm reduction in the mainstream of public health.

Entities:  

Mesh:

Year:  2008        PMID: 18281206     DOI: 10.1016/j.drugpo.2007.12.012

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

1.  HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities.

Authors:  Catherine S Todd; Abdul Nasir; Mohammad R Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  AIDS       Date:  2010-07       Impact factor: 4.177

2.  The spread of HIV in Pakistan: bridging of the epidemic between populations.

Authors:  Muhammad R Khanani; Mehreen Somani; Sadiq S Rehmani; Nazle M C Veras; Marco Salemi; Syed H Ali
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

Review 3.  Review of HIV response in Pakistan using a system thinking framework.

Authors:  Muhammad Ahmed Abdullah; Babar Tasneem Shaikh
Journal:  Glob Health Action       Date:  2015-03-30       Impact factor: 2.640

4.  High HIV incidence among persons who inject drugs in Pakistan: greater risk with needle sharing and injecting frequently among the homeless.

Authors:  Rab Nawaz Samo; Arshad Altaf; Ajmal Agha; Omrana Pasha; Shafquat Rozi; Ashraf Memon; Saleem Azam; Meridith Blevins; Sten H Vermund; Sharaf Ali Shah
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

Review 5.  HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.

Authors:  Ghina R Mumtaz; Helen A Weiss; Sara L Thomas; Suzanne Riome; Hamidreza Setayesh; Gabriele Riedner; Iris Semini; Oussama Tawil; Francisca Ayodeji Akala; David Wilson; Laith J Abu-Raddad
Journal:  PLoS Med       Date:  2014-06-17       Impact factor: 11.069

6.  The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.

Authors:  Sarwat Mahmud; Ghina R Mumtaz; Hiam Chemaitelly; Zaina Al Kanaani; Silva P Kouyoumjian; Joumana G Hermez; Laith J Abu-Raddad
Journal:  Addiction       Date:  2020-02-03       Impact factor: 6.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.